CRNX
Price
$30.14
Change
+$0.19 (+0.63%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
2.81B
78 days until earnings call
CTMX
Price
$2.12
Change
+$0.08 (+3.92%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
321.39M
77 days until earnings call
Interact to see
Advertisement

CRNX vs CTMX

Header iconCRNX vs CTMX Comparison
Open Charts CRNX vs CTMXBanner chart's image
Crinetics Pharmaceuticals
Price$30.14
Change+$0.19 (+0.63%)
Volume$7.81K
Capitalization2.81B
CytomX Therapeutics
Price$2.12
Change+$0.08 (+3.92%)
Volume$17.07K
Capitalization321.39M
CRNX vs CTMX Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. CTMX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and CTMX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CRNX: $29.95 vs. CTMX: $2.04)
Brand notoriety: CRNX and CTMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 67% vs. CTMX: 53%
Market capitalization -- CRNX: $2.81B vs. CTMX: $321.39M
CRNX [@Biotechnology] is valued at $2.81B. CTMX’s [@Biotechnology] market capitalization is $321.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileCTMX’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • CTMX’s FA Score: 0 green, 5 red.
According to our system of comparison, CTMX is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while CTMX’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 5 bearish.
  • CTMX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CTMX is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а -4.28% price change this week, while CTMX (@Biotechnology) price change was -14.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.57%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was -2.23%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

CTMX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.81B) has a higher market cap than CTMX($321M). CTMX YTD gains are higher at: 98.058 vs. CRNX (-41.424). CTMX has higher annual earnings (EBITDA): 26.8M vs. CRNX (-336.07M). CRNX has more cash in the bank: 1.35B vs. CTMX (101M). CTMX has less debt than CRNX: CTMX (9.39M) vs CRNX (51.7M). CTMX has higher revenues than CRNX: CTMX (138M) vs CRNX (1.04M).
CRNXCTMXCRNX / CTMX
Capitalization2.81B321M874%
EBITDA-336.07M26.8M-1,254%
Gain YTD-41.42498.058-42%
P/E RatioN/A4.25-
Revenue1.04M138M1%
Total Cash1.35B101M1,341%
Total Debt51.7M9.39M551%
FUNDAMENTALS RATINGS
CRNX vs CTMX: Fundamental Ratings
CRNX
CTMX
OUTLOOK RATING
1..100
1319
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
6434
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTMX's Valuation (72) in the Biotechnology industry is in the same range as CRNX (92) in the Pharmaceuticals Major industry. This means that CTMX’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (69) in the Pharmaceuticals Major industry is in the same range as CTMX (100) in the Biotechnology industry. This means that CRNX’s stock grew similarly to CTMX’s over the last 12 months.

CRNX's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as CTMX (99) in the Biotechnology industry. This means that CRNX’s stock grew similarly to CTMX’s over the last 12 months.

CTMX's Price Growth Rating (34) in the Biotechnology industry is in the same range as CRNX (64) in the Pharmaceuticals Major industry. This means that CTMX’s stock grew similarly to CRNX’s over the last 12 months.

CTMX's P/E Growth Rating (95) in the Biotechnology industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that CTMX’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXCTMX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 7 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 4 days ago
75%
Declines
ODDS (%)
Bearish Trend 17 days ago
79%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X109678.0800002886.992200
+2.70%
Bitcoin cryptocurrency
GME28.05-0.46
-1.61%
GameStop Corp
SPY582.86-9.99
-1.69%
SPDR® S&P 500® ETF
AAPL202.09-4.77
-2.31%
Apple
TSLA334.62-9.20
-2.68%
Tesla

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-4.53%
XNCR - CRNX
57%
Loosely correlated
-7.62%
TRDA - CRNX
56%
Loosely correlated
-6.67%
IDYA - CRNX
56%
Loosely correlated
-2.45%
RVMD - CRNX
55%
Loosely correlated
-4.27%
KYMR - CRNX
55%
Loosely correlated
-4.17%
More

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with REGN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then REGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-0.97%
REGN - CTMX
38%
Loosely correlated
-1.65%
BCAB - CTMX
37%
Loosely correlated
-2.40%
CRNX - CTMX
37%
Loosely correlated
-4.53%
NKTR - CTMX
37%
Loosely correlated
-7.95%
APGE - CTMX
35%
Loosely correlated
-0.40%
More